HSPA5 and non-small cell lung carcinoma: Prior studies have implicated that EPB41L3 can attenuate epithelial-mesenchymal transition (EMT) and metastasis by suppressing heat shock protein 5 (HSPA5) in non-small cell lung cancer (NSCLC) [27, 28].